Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Wss1 metalloprotease partners with Cdc48/Doa1 in processing genotoxic SUMO conjugates.

Balakirev MY, Mullally JE, Favier A, Assard N, Sulpice E, Lindsey DF, Rulina AV, Gidrol X, Wilkinson KD.

Elife. 2015 Sep 8;4. doi: 10.7554/eLife.06763.

2.

The ubiquitin binding domain ZnF UBP recognizes the C-terminal diglycine motif of unanchored ubiquitin.

Reyes-Turcu FE, Horton JR, Mullally JE, Heroux A, Cheng X, Wilkinson KD.

Cell. 2006 Mar 24;124(6):1197-208.

3.

Doa1 is a Cdc48 adapter that possesses a novel ubiquitin binding domain.

Mullally JE, Chernova T, Wilkinson KD.

Mol Cell Biol. 2006 Feb;26(3):822-30.

5.

The ubiquitin signal: assembly, recognition and termination. Symposium on ubiquitin and signaling.

Wilkinson KD, Ventii KH, Friedrich KL, Mullally JE.

EMBO Rep. 2005 Sep;6(9):815-20. Review. No abstract available.

6.

Curcumin impairs tumor suppressor p53 function in colon cancer cells.

Moos PJ, Edes K, Mullally JE, Fitzpatrick FA.

Carcinogenesis. 2004 Sep;25(9):1611-7. Epub 2004 Apr 16.

PMID:
15090465
7.

Punaglandins, chlorinated prostaglandins, function as potent Michael receptors to inhibit ubiquitin isopeptidase activity.

Verbitski SM, Mullally JE, Fitzpatrick FA, Ireland CM.

J Med Chem. 2004 Apr 8;47(8):2062-70.

PMID:
15056003
8.
9.

Cyclopentenone prostaglandins of the J series inhibit the ubiquitin isopeptidase activity of the proteasome pathway.

Mullally JE, Moos PJ, Edes K, Fitzpatrick FA.

J Biol Chem. 2001 Aug 10;276(32):30366-73. Epub 2001 Jun 4.

10.

Survey of patients with granular, lattice, avellino, and Reis-B├╝cklers corneal dystrophies for mutations in the BIGH3 and gelsolin genes.

Afshari NA, Mullally JE, Afshari MA, Steinert RF, Adamis AP, Azar DT, Talamo JH, Dohlman CH, Dryja TP.

Arch Ophthalmol. 2001 Jan;119(1):16-22.

PMID:
11146721

Supplemental Content

Loading ...
Support Center